Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular erythropoietin versus dextrose for knee osteoarthritis
IRCT20170910036107N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Dextrose prolotherapy with Intra-articular erythropoietin (2 arms). Primary endpoints: Visual analog scale at 6 months and WOMAC questionnaire at 6 months. Started May 2024; status: completed.
02
Drugs
erythropoietindextrose
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20170910036107N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170910036107N8.